| Literature DB >> 30273357 |
Nam Hyo Kim1, Young Ah Youn2, Su Jin Cho3, Jong-Hee Hwang4, Ee-Kyung Kim5, Ellen Ai-Rhan Kim6, Soon Min Lee7.
Abstract
The critical need to emphasize preterm infant follow-up after neonatal intensive care unit (NICU) discharge assures early identification of and intervention for neurodevelopmental disability. The aims of this study were to observe the follow-up rates in high-risk follow-up clinics, and analyze factors associated with non-compliance to follow-up among very low birth weight (VLBW) infants. The data was prospectively collected for 3063 VLBW infants between January 2013 and December 2014 from 57 Korean neonatal network (KNN) centers at a corrected age of 18-24 months. Correlations among demographic data, clinical variables, and neonatal intensive care unit (NICU) volume (divided into 4 quartiles) with the occurrence of non-compliance were analyzed. The overall follow-up rate at the corrected age of 18-24 month was 65.4%. The follow-up rates were inversely related to birth weight and gestational age. Apgar score, hospital stay, maternal age, and maternal education were significantly different between the compliance and non-compliance groups. The follow-up rate was higher for mothers with chorioamnionitis, abnormal amniotic fluid, multiple pregnancy, and in vitro fertilization. Infants with respiratory distress syndrome, bronchopulmonary dysplasia, patent ductus arteriosus ligation, periventricular leukomalacia, and retinopathy of prematurity were more common in the compliance group. Follow-up rates showed significant differences according to NICU volume. Using multivariate logistic regression, high birth weight, low NICU volume, siblings, foreign maternal nationality and high 5 min APGAR scores were significant independent factors associated with the non-compliance of VLBW infants for follow-up at 18-24 months of age. This is the first nation-wide analysis of follow-up for VLBW infants in Korea. Understanding factors associated with failure of compliance could help improve the long-term follow-up rates and neurodevelopmental outcomes through early intervention.Entities:
Mesh:
Year: 2018 PMID: 30273357 PMCID: PMC6166943 DOI: 10.1371/journal.pone.0204421
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Differences in relevant clinical variables between compliant and non-compliant groups.
| Compliant | Non-compliant | Total | P Value | |
|---|---|---|---|---|
| 322 (17.2) | 123 (13.0) | 445 (15.8) | 0.004 | |
| 732 (36.5) | 332 (31.3) | 1064 (34.7) | 0.004 | |
| 455 (22.7) | 197 (18.6) | 652 (21.3) | 0.008 | |
| 722 (36.0) | 449 (42.4) | 1171 (38.2) | 0.001 | |
| 32.83 [3.95] | 32.32 [4.61] | 32.66 [4.20] | 0.002 | |
| 0.000 | ||||
| high school or less | 426 (24.6) | 263 (33.2) | 689 (27.3) | |
| college or higher | 1303 (75.4) | 530 (66.8) | 1833 (72.7) | |
| 0.000 | ||||
| Korean | 1954 (97.6) | 1006 (94.9) | 2960 (96.6) | |
| foreign country | 49 (2.4) | 54 (5.1) | 103 (3.4) | |
| 164 (8.2) | 91 (8.6) | 255 (8.3) | 0.731 | |
| 405 (20.2) | 244 (23.0) | 649 (21.2) | 0.077 | |
| 588 (34.1) | 252 (29.8) | 840 (32.7) | 0.032 | |
| 717 (36.0) | 376 (35.8) | 1093 (35.9) | 0.937 | |
| 1013 (50.6) | 524 (49.4) | 1537 (50.2) | 0.569 | |
| 1514 (75.6) | 802 (75.7) | 2316 (75.6) | 1.000 | |
| 446 (23.1) | 255 (24.9) | 701 (23.7) | 0.296 | |
| 29.02 [2.79] | 26.65 [2.92] | 29.23 [2.85] | 0.000 | |
| 1093.76 [270.31] | 1158.56 [245.29] | 1116.19 [263.69] | 0.000 | |
| 4.73 [1.93] | 5.03 [1.99] | 4.84 [1.96] | 0.000 | |
| 6.87 [1.65] | 7.11 [1.69] | 6.95 [1.67] | 0.000 | |
| 72.97 [36.90] | 67.03 [39.22] | 70.92 [37.82] | 0.000 |
Data are expressed as number of patient (%) or mean [standard deviation]. IVF, in vitro fertilization; GDM, gestational diabetes mellitus; PIH, pregnancy-induced hypertension; PROM, premature rupture of membrane; C/Sec, caesarean section; SGA, small for gestational age; d, days; g, gram.
Fig 1Follow-up rates after NICU discharge of VLBW infants by (A) birth weight and (B) gestational age.
Comparisons of morbidities between compliant and non-compliant groups.
| Compliant | Non-compliant | P Value | |
|---|---|---|---|
| 1571 (78.4) | 756 (71.3) | 0.000 | |
| 82 (4.1) | 25 (2.4) | 0.013 | |
| 92 (4.6) | 39 (3.7) | 0.260 | |
| 96 (4.8) | 46 (4.3) | 0.589 | |
| 739 (36.9) | 362 (34.2) | 0.133 | |
| 269 (12.9) | 111 (10.5) | 0.048 | |
| 622 (31.2) | 292 (27.9) | 0.067 | |
| 279 (13.9) | 132 (12.5) | 0.266 | |
| 68 (24.4) | 39 (29.5) | 0.280 | |
| 154 (7.7) | 105 (10.0) | 0.034 | |
| 88 (4.4) | 47 (4.4) | 1.000 | |
| 395 (19.7) | 212 (20.0) | 0.849 | |
| 482 (24.7) | 201 (20.3) | 0.007 | |
| 213 (17.2) | 73 (11.8) | 0.002 | |
| 296 (16.3) | 108 (12.0) | 0.003 | |
| 59 (2.9) | 21 (2.0) | 0.122 | |
| 16.08 [25.18] | 14.18 [25.99] | 0.049 | |
| 9.51 [14.55] | 8.27 [14.96] | 0.028 |
Data are expressed as number of patient (%) or mean [standard deviation]. RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; BPD, bronchopulmonary dysplasia; IVH, intraventricular haemorrhage; PVL, periventricular leukomalacia; NEC, necrotizing enterocolitis; ROP, retinopathy of prematurity; d, days.
Comparative analysis of compliance to follow-up clinic after discharge according to NICU volume.
| 0.000 | |||
| Group 1 | 436 (56.0) | 343 (44.0) | |
| Group 2 | 505 (64.1) | 283 (35.9) | |
| Group 3 | 495 (57.7) | 363 (42.3) | |
| Group 4 | 567 (88.9) | 71 (11.1) | |
| 0.582 | 0.492, 0.687 | 0.000 | |
| 0.926 | 0.781, 1.096 | 0.371 | |
| 0.630 | 0.536, 0.741 | 0.000 | |
| 5.500 | 4.242, 7.131 | 0.000 |
Data are expressed as number of patient (%).
Quartile for NICU volume is based on average annual VLBW discharge volume for 2013 and 2014, expressed as mean ± standard deviation. 1st quartile, 26.4 ± 14.1; 2nd quartile, 70.5 ± 11.3; 3rd quartile, 141.6 ± 32.6; 4th quartile, 239.7 ± 23.6.
Results of multivariable logistic regression model for non-compliance to follow-up clinic for VLBW infants.
| OR | 95% CI | P Value | |
|---|---|---|---|
| 0.869 | 0.642, 1.178 | 0.366 | |
| 1.311 | 1.028, 1.673 | 0.029 | |
| 0.972 | 0.945, 1.000 | 0.047 | |
| high school or less | 1.231 | 0.962, 1.575 | 0.099 |
| college or higher | 1.0 | reference | |
| Korean | 1.0 | reference | |
| foreign country | 2.059 | 1.090, 3.889 | 0.026 |
| 1.114 | 0.813, 1.526 | 0.501 | |
| 0.944 | 0.744, 1.198 | 0.634 | |
| 1.497 | 0.718, 3.123 | 0.282 | |
| 1.111 | 0.829, 1.490 | 0.480 | |
| 1.123 | 1.040, 1.213 | 0.003 | |
| 0.762 | 0.517, 1.124 | 0.171 | |
| 1.052 | 0.753, 1.471 | 0.765 | |
| 0.759 | 0.477, 1.209 | 0.246 | |
| 1.141 | 0.831, 1.567 | 0.414 | |
| 0.992 | 0.983, 1.001 | 0.074 | |
| 1.003 | 0.998, 1.008 | 0.261 | |
| 0.000 | |||
| Group 1 | 5.422 | 3.696, 7.953 | 0.000 |
| Group 2 | 3.652 | 2.484, 5.370 | 0.000 |
| Group 3 | 5.877 | 4.080, 8.467 | 0.000 |
| Group 4 | 1.0 | reference | |
| 0.028 | |||
| ≤ 750 g | 1.0 | reference | |
| 751–1000 g | 1.324 | 0.829, 2.115 | 0.239 |
| 1001–1250 g | 1.513 | 0.908, 2.523 | 0.112 |
| 1251–1499 g | 2.044 | 1.193, 3.504 | 0.009 |
VLBW, very low birth weight; IVF, in vitro fertilization; RDS, respiratory distress syndrome; PDA, patent ductus arteriosus; ROP, retinopathy of prematurity; PVL, periventricular leukomalacia; NICU, neonatal intensive care unit